Cannasouth Limited and Group reported a operating loss of $3,546,495 for the six months ending June 30, 2023, compared to a loss of $2,476,560 in the same period last year.
The company's cash on hand as of June 30, 2023, was $5.32 million, compared to $1.46 million in 2022.
Cannasouth completed a merger with Eqalis Group in May 2023, positioning itself as a leader in the New Zealand medicinal cannabis industry.
The company plans to undertake a dual listing on the ASX in the near term.
Cannasouth achieved several milestones during the period, including obtaining a GMP Licence to Manufacture Medicines and exporting its first commercial-scale shipment of dried cannabis flower to Australia.
The company also submitted product applications for prescription in New Zealand and announced its intention to dual list on the ASX.
See more
